Molecure (WAR:MOC) Issuance of Debt: zł0.00 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MOC Molecure SA WAR:MOC
27 GF Score
Price zł6.15
! 3 Warning Signs
View Full Analysis

What is Molecure Issuance of Debt?

Molecure WAR:MOC +1.32% 27 Issuance of Debt is zł0.00 Mil as of Sep. 2025. GuruFocus rates WAR:MOC with a GF Score™ of 27/100. The stock has 3 warning signs investors should review.

Molecure's Issuance of Debt for the three months ended in Sep. 2025 was zł0.00 Mil.

Molecure's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2025 was zł0.00 Mil.

Molecure Issuance of Debt Related Terms

Molecure Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Molecure's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecure Issuance of Debt Chart

Molecure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Molecure Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:MOC
27GF Score
Molecure SA WAR:MOC
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molecure Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of zł0.00 Mil mean?
Molecure (WAR:MOC) has a Issuance of Debt of zł0.00 Mil as of Sep. 2025. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Molecure and its competitors.
Is Molecure's Issuance of Debt too high?
Molecure's current Issuance of Debt is zł0.00 Mil. Overall, Molecure has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Molecure's Issuance of Debt compare to VRTX and REGN?
Molecure's Issuance of Debt of zł0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Biotechnology company?
A good Issuance of Debt depends on the Biotechnology industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Molecure and its competitors. Molecure's current Issuance of Debt is zł0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecure stock overvalued right now?
Molecure (WAR:MOC) has a current Issuance of Debt of zł0.00 Mil. The current Issuance of Debt is zł0.00 Mil. Molecure's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Molecure (WAR:MOC), the current Issuance of Debt is zł0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecure Business Description

Other Exchanges 1B1:Germany
Address Zwirki i Wigury 101, Warsaw, POL, 02-089
Molecure SA is a biopharmaceutical company engaged in discovering, developing, and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.
27GF Score

Get the complete analysis for WAR:MOC

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł6.15
Price